Skip to content

Assessment of Quality of Life of Patients During Treatment for Bone Cancers

Assessment of Quality of Life of Patients During Treatment for Primary Malignant Skeletal Tumors: A Interdisciplinary Approach to Enhancing the Standard of Care - Nil

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/09/058089
Enrollment
50
Registered
2023-09-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C40- Malignant neoplasm of bone and articular cartilage of limbs

Interventions

Control Intervention1: Nil: Nil

Sponsors

Indo American Cancer Hsopital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Ability to read and write in English / regional language and to personally give informed consent 2. Good mental status 3. Appropriate age: above 8 years diagnosed with histologically confirmed primary bone tumor are included in the study

Exclusion criteria

Exclusion criteria: 1. All soft tissue tumors 2. Metastatic bone tumors 3. Patients who have not consented 4. Patients who are already on on going treatment for their cancer

Design outcomes

Primary

MeasureTime frame
To assess the HRQoL(Health related quality of life) of patients during treatment for Primary Malignant Skeletal TumorsTimepoint: Base line, 1 week post Palliative Consultaion, post 2 cycles fo chemo, 2 weeks post surgery, at the end of treatment

Secondary

MeasureTime frame
The impact of multiple potential variables, including gender, cancer type, age, & other demographic traits, on QoL & symptom management by palliative physician will be evaluated.Timepoint: Base line, 1 week post Palliative Consultaion, post 2 cycles fo chemo, 2 weeks post surgery, at the end of treatment

Countries

India

Contacts

Public ContactDr Divya Sai

Indo American Cancer Hsopital

praneethsuv@gmail.com9814686999

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026